HPV Vaccination in Kenya
The Challenges Faced and Strategies to Increase Uptake
Bibliographic Data
| ID | 22067190 |
|---|---|
| Authors | Christine Karanja-Chege (0000-0002-2272-5761, Kenyatta University, corresponding author), Christine Muthoni Karanja-Chege |
| Year | 2022 |
| Volume | 10 |
| Pages | 802947-802947 |
| Publication date | 2022-03-21 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Public Health (JOURNAL) |
| Journal identifiers | ISSN: 2296-2565 • E-ISSN: 2296-2565 |
| Publisher | Frontiers Media SA (PUBLISHER • CH) |
| DOI | 10.3389/fpubh.2022.802947 |
| PMID | 35387182 |
| OpenAlex | W4220919414 |
| Language | EN |
| Citations received | 11 |
| References cited | 13 |
Human papilloma virus (HPV) is the leading cause of ano-genital cancers globally with cervical cancer as the top cause of cancer- related deaths in women. Over 90% of these deaths occur in low income countries where cancer control strategies remain inadequate. HPV vaccination provides protection against HPV types 16 and 18 which are responsible for approximately 70% of cervical cancer cases. The optimal age of vaccination is in the early adolescent period, before sexual debut with possible HPV infection. Studies have shown that children residing in low income settlements are at risk of early initiation of sexual activity. Adolescent vaccination programs would provide an avenue to link other health promotion strategies targeting this age group that has hitherto been left out of many health interventions in 2019, Kenya introduced HPV vaccine to be given to 10 year old girls. Uptake has been sub-optimal with only 33% of targeted population receiving the first dose in 2020 and 16% returning for the 2nd dose. While disruption of immunization programs by the COVID-19 pandemic contributed to the low coverage, other factors such as low demand fuelled by misinformation have also played a role
Cancer · Cervical cancer · Disease · Environmental health · Gardasil · Genital warts · HPV infection · HPV vaccines · Immune system · Immunization · Misinformation · Pandemic · Population · Psychological intervention · Vaccination · Cervical Cancer and HPV Research · Demography · Hepatitis B Virus Studies · Medicine · Vaccine Coverage and Hesitancy · Immunology · Internal Medicine
Exploring the factors contributing to low vaccination uptake for nationally recommended routine childhood and adolescent vaccines in Kenya
Strengthening vaccine uptake
HPV vaccination in Africa in the Covid-19 era
An urgent call to include men who have sex with men in the HPV immunisation programme in Kenya
Neglected cancer care needs among the nomadic pastoralist communities in sub-Saharan Africa
Toward improving anal health care among GBMSM in Kenya
Integrating Anogenital Health Care Into HIV Programs for Queer Men in Kenya
Evaluation of video-assisted HPV education in government-supported clinics in Western Kenya
Community engagement for vaccine delivery in low- and middle-income countries and humanitarian settings
The impact of the Covid-19 pandemic on cancer care including innovations implemented in Sub-Saharan Africa
Understanding Kenyan policymakers’ perspectives about the introduction of new maternal vaccines
| Citations per year | 2.75 |
|---|---|
| Citation span | 2022 - 2026 (5) |
| Highly cited | No |